SCHEMBL24287258

SCHEMBL24287258

Cc1ccccc1Oc1nc2ccccc2nc1C

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.50
▸ TSHR P16473 2/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ HPGD P15428 3/20 0.45
▸ CYP1A2 P05177 3/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ MRGPRX1 Q96LB2 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.42
▸ NQO2 P16083 1/20 0.42
▸ MAPT P10636 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24287259 0.82 GAA (0.56) SMN1; SMN2L3MBTL1TSHRMEN1KMT2A
SCHEMBL18796404 0.81 LCK (0.52) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL18796088 0.81 L3MBTL1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1TSHRHPGD
SCHEMBL16795314 0.81 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL26813123 0.79 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL24287256 0.79 L3MBTL1 (0.45) ALDH1A1L3MBTL1TSHRHPGDCYP1A2
SCHEMBL22372364 0.78 L3MBTL1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL24287257 0.77 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2L3MBTL1TSHRHPGD
SCHEMBL804981 0.75 TSHR (0.61) ALDH1A1SMN1; SMN2L3MBTL1TSHRMEN1
SCHEMBL11401433 0.75 L3MBTL1 (0.74) SMN1; SMN2L3MBTL1TSHRHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076629-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback